Kelyniam Global

53 articles about Kelyniam Global

• Strong Fourth Quarter Powers 2023 Kelyniam Financials

  3/17/2024

  Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2023.

• Kelyniam Global Releases 3rd Quarter 2023 Financials

  12/21/2023

  Kelyniam Global, a maker of custom cranial implants, announced results for its third quarter ended September 30, 2023.

• Kelyniam Global Releases 2nd Quarter 2023 Financials

  8/14/2023

  Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2023.

• Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

  5/22/2023

  Kelyniam Global, a leading maker of custom cranial implants, announced results for its quarter ended March 31, 2023.

• Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements

  3/17/2023

  Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2022.

• Kelyniam Global Announces 3rd Quarter Results

  11/15/2022

  Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended September 30, 2022.

• Kelyniam Global Announces 1st Half Results Outstanding Quarter and Sales Momentum into the Second Half

  8/15/2022

  Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended June 30, 2022.

• Kelyniam Announces New Vice President of Sales and Strategic Development

  7/11/2022

  Kelyniam Global, a maker of custom cranial implants, announced the Board Member Desiree Webb is joining the commercial team to lead Sales and Strategic Development as Vice President.

• Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements

  2/14/2022

  Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2021.

• Kelyniam Global, Inc. OTC Trading & Business Matters Update

  9/30/2021

  Kelyniam Global, a maker of custom cranial implants, is pleased to announce that the company has submitted all of the documentation required for establishment as a "Pink Current" filer under the new SEC Rule 15c2-11 ahead of schedule for the September 30, 2021 deadline.

• Kelyniam Global Releases 2nd Quarter 2021 Financials Maintains Profitability - Covid Challenges Continue

  8/23/2021

  Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2021.

• Kelyniam Global Releases Q1 Financial Results - Profitability Despite the 2nd Wave Pandemic

  5/18/2021

  Kelyniam Global, a maker of custom cranial implants, has released its financial results for the three months ended March 31, 2021 showing profitability despite pandemic related challenges.

• Kelyniam Global Releases Annual 2020 Financials

  4/2/2021

  Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2020.

• Kelyniam Global Releases 3rd Quarter 2020 Financials Steady Growth and a Focus on Profitability Despite Covid-19

  11/16/2020

  Kelyniam Global, a maker of custom cranial implants, announced results for its third quarter ended September 30, 2020.

• Kelyniam Global Releases 2nd Quarter 2020 Financials

  9/1/2020

  Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2020.

• Kelyniam Global Releases 2019 Financials

  5/18/2020

  Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its fourth quarter and full year ended December 31 , 2019.  "Kelyniam achieved record sales in 2019, growing slightly over 2018's strong performance," said Ross Bjella , Kelyniam's CEO.  "This marks three years in a row with positive grow

• Kelyniam Settles Arbitration, Adds Executives

  5/7/2020

  Kelyniam Global, a maker of custom craniomaxilofacial implants, announced that the company has reached a settlement agreement with the former CEO and has added two members to the senior executive team.

• Kelyniam Global Announces 510(k) Clearance for Integrated Fixation System for Custom Skull Implants

  5/24/2019

  Kelyniam Global, a maker of custom cranial and craniofacial implants, announced that it has received premarket approval from the Food and Drug Administration for a new 510 application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line.

• Kelyniam Global, Inc. Addresses Shareholders - March 5, 2019

  3/5/2019

  Kelyniam achieved record sales in 2018 by growing 15% to $2,123,699, marking two years in a row of double digit growth.

• Kelyniam Submits Third 510(k) Application

  10/23/2018

  Kelyniam Global, Inc., (KLYG), a maker of patient specific craniofacial and skull implants, announced the submission of its third 510(k) application to the FDA to expand their line of custom implants.